Terms: = Lymphoma AND GRIN2A, Q12879, 2903, ENSG00000183454, NMDAR2A, NR2A
5 results:
1. Prognostic and predictive value of a microRNA signature in adults with T-cell lymphoblastic lymphoma.
Tian XP; Huang WJ; Huang HQ; Liu YH; Wang L; Zhang X; Lin TY; Rao HL; Li M; Liu F; Zhang F; Zhong LY; Liang L; Lan XL; Li J; Liao B; Li ZH; Tang QL; Liang Q; Shao CK; Zhai QL; Cheng RF; Sun Q; Ru K; Gu X; Lin XN; Yi K; Shuang YR; Chen XD; Dong W; Sang W; Sun C; Liu H; Zhu ZG; Rao J; Guo QN; Zhou Y; Meng XL; Zhu Y; Hu CL; Jiang YR; Zhang Y; Gao HY; He WJ; Xia ZJ; Wu CL; Zhang MY; Wang HY; Xie D; Cai QQ
Leukemia; 2019 Oct; 33(10):2454-2465. PubMed ID: 30953029
[TBL] [Abstract] [Full Text] [Related]
2. BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.
Ito Y; Umezu T; Tadokoro K; Saito Y; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Tanaka Y; Fujimoto H; Okabe S; Gotoh M; Tauchi T; Kawana C; Ohyashiki JH; Nakamura N; Ohyashiki K
Leuk Lymphoma; 2019 May; 60(5):1283-1288. PubMed ID: 30480474
[TBL] [Abstract] [Full Text] [Related]
3. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-nr2a/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
Levite M
J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
[TBL] [Abstract] [Full Text] [Related]
4. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
[TBL] [Abstract] [Full Text] [Related]
5. Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.
Okayama H; Kohno T; Ishii Y; Shimada Y; Shiraishi K; Iwakawa R; Furuta K; Tsuta K; Shibata T; Yamamoto S; Watanabe S; Sakamoto H; Kumamoto K; Takenoshita S; Gotoh N; Mizuno H; Sarai A; Kawano S; Yamaguchi R; Miyano S; Yokota J
Cancer Res; 2012 Jan; 72(1):100-11. PubMed ID: 22080568
[TBL] [Abstract] [Full Text] [Related]
